Healthpeak Properties, Inc. (NYSE:DOC) Shares Bought by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. lifted its position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 5.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 640,955 shares of the real estate investment trust's stock after purchasing an additional 31,799 shares during the period. Robeco Institutional Asset Management B.V. owned about 0.09% of Healthpeak Properties worth $12,992,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. HM Payson & Co. purchased a new stake in Healthpeak Properties during the 3rd quarter worth about $25,000. S.A. Mason LLC purchased a new stake in Healthpeak Properties during the third quarter worth approximately $26,000. Rise Advisors LLC acquired a new position in Healthpeak Properties in the third quarter valued at approximately $29,000. Fortitude Family Office LLC purchased a new position in Healthpeak Properties in the third quarter valued at approximately $32,000. Finally, Barrett & Company Inc. acquired a new stake in Healthpeak Properties during the third quarter worth approximately $33,000. Institutional investors and hedge funds own 93.57% of the company's stock.

Analysts Set New Price Targets

DOC has been the subject of several research analyst reports. Mizuho lowered their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a report on Thursday, December 5th. Deutsche Bank Aktiengesellschaft raised shares of Healthpeak Properties from a "hold" rating to a "buy" rating and boosted their price target for the company from $20.00 to $28.00 in a research report on Monday, October 21st. Royal Bank of Canada raised their price objective on Healthpeak Properties from $25.00 to $26.00 and gave the stock an "outperform" rating in a report on Monday, November 4th. Wells Fargo & Company reduced their target price on Healthpeak Properties from $23.00 to $22.00 and set an "equal weight" rating for the company in a report on Tuesday, December 10th. Finally, StockNews.com downgraded Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Wednesday, October 30th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $24.15.

Healthpeak Properties Stock Performance

Shares of Healthpeak Properties stock traded down $0.34 during trading hours on Tuesday, hitting $20.05. 8,689,489 shares of the company were exchanged, compared to its average volume of 4,566,750. The company has a current ratio of 1.31, a quick ratio of 1.31 and a debt-to-equity ratio of 0.93. The business has a 50-day moving average of $20.67 and a 200-day moving average of $21.54. Healthpeak Properties, Inc. has a 1 year low of $16.01 and a 1 year high of $23.26. The stock has a market capitalization of $14.02 billion, a price-to-earnings ratio of 42.65, a P/E/G ratio of 2.22 and a beta of 1.15.

Healthpeak Properties Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 26th. Shareholders of record on Friday, February 14th will be given a dividend of $0.305 per share. The ex-dividend date is Friday, February 14th. This represents a $1.22 dividend on an annualized basis and a yield of 6.09%. This is an increase from Healthpeak Properties's previous quarterly dividend of $0.30. Healthpeak Properties's dividend payout ratio is presently 255.32%.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.